The Application of Deuteration Strategy in Drug Design

被引:0
|
作者
Chen, Yuzhu [1 ]
Du, Yunfei [1 ]
机构
[1] Tianjin Univ, Fac Med, Sch Pharmaceut Sci & Technol, 92 Weijin Rd, Tianjin, Peoples R China
基金
中国国家自然科学基金;
关键词
Deuterium; Deuterated drugs; Drug design; Pharmacokinetic properties; Metabolism; ALTERING METABOLIC PROFILES; KINASE INHIBITOR; DEUTERIUM; DEUTETRABENAZINE; CLOPIDOGREL; DISEASE; PHARMACOKINETICS; CANDIDATE; DISCOVERY; LEVODOPA;
D O I
10.1002/cmdc.202400836
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Deuterated drugs, which are derived from the subtle exchange of a protium atom with a deuterium atom in drug molecules, exhibit significant differences in pharmaceutical characteristics compared to their parent drugs. With the advantages of improving pharmacokinetic properties, reducing toxicity, inhibiting the interconversion between chiral drugs and restricting drug interactions, deuterated drugs have attracted widespread attention from medicinal chemists. This review highlights the application of deuteration strategies in drug design, summarizing the progress of all deuterated drugs available in the market or still under investigation to provide a reference for all researchers engaged deuterated drug development.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Deuteration in drug discovery
    Li, Feng
    Jiang, Wenfeng
    Czarnik, Anthony
    Li, Wenbao
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [2] STRATEGY IN DRUG DESIGN
    HANSCH, C
    CANCER CHEMOTHERAPY REPORTS PART 1, 1972, 56 (04): : 433 - &
  • [3] MITIGATION OF DRUG TO DRUG INTERACTIONS OF MIBEFRADIL WITH STRATEGIC DEUTERATION
    Gallegos, Richard
    Bridson, Gary Gary
    Pandya, Bhaumik
    Harbeson, Scott
    Uttamsingh, Vinita
    Tung, Roger
    DRUG METABOLISM REVIEWS, 2012, 44 : 72 - 72
  • [4] Drug Self-Delivery Systems: Molecule Design, Construction Strategy, and Biological Application
    Liu, Chengfei
    Liu, Caiping
    Bai, Yang
    Wang, Jingxia
    Tian, Wei
    ADVANCED HEALTHCARE MATERIALS, 2023, 12 (10)
  • [5] Application of Drug Repositioning Strategy to TOFISOPAM
    Bernard, P.
    Dufresne-Favetta, C.
    Favetta, P.
    Do, Q. -T.
    Himbert, F.
    Zubrzycki, S.
    Scior, T.
    Lugnier, C.
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (30) : 3196 - 3203
  • [6] Drug design strategy aims for disorder
    不详
    CHEMICAL & ENGINEERING NEWS, 2008, 86 (09) : 31 - 31
  • [7] Polyvalency: A promising strategy for drug design
    Vance, David
    Shah, Mrinal
    Joshi, Amit
    Kane, Ravi S.
    BIOTECHNOLOGY AND BIOENGINEERING, 2008, 101 (03) : 429 - 434
  • [8] QSAR - Application in Drug Design
    Malik, Jitender K.
    Soni, Himesh
    Singhai, A. K.
    Pandey, Harish
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2013, 2 (01): : 1 - 13
  • [9] Application of Sulfonyl in Drug Design
    Zhao, Fei
    Wang, Jiang
    Ding, Xiao
    Shu, Shuangjie
    Liu, Hong
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2016, 36 (03) : 490 - 501
  • [10] Application of Nitrile in Drug Design
    Wang, Jiang
    Liu, Hong
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2012, 32 (09) : 1643 - 1652